Assessment of sensitivity to potential outcome misclassification when estimating the relative excess of HPV-associated malignancies among pediatric and young adult (PAYA) cancer survivors compared with the general United States (US) population.

aStandardized incidence ratio after applying classification rates for PAYA cases and the general US population;
bAssumed to be negligible because of an extensive confirmation process for cases submitted to the SEER program.